Ferri's Clinical Advisor 2021: 5 Books in 1 Fred F. Ferri MD FACP Fred F. Ferri MD Facppdf Download
Ferri's Clinical Advisor 2021: 5 Books in 1 Fred F. Ferri MD FACP Fred F. Ferri MD Facppdf Download
or textbooks at https://ebookmass.com
https://ebookmass.com/product/ferris-clinical-
advisor-2021-5-books-in-1-fred-f-ferri-md-facp-fred-f-ferri-
md-facp/
https://ebookmass.com/product/ferris-clinical-advisor-2019-fred-f-
ferri/
https://ebookmass.com/product/ferris-clinical-advisor-2021-5-books-
in-1-1st-edition-fred-ferri/
https://ebookmass.com/product/ferris-clinical-advisor-2018-20th-
edition-fred-f-ferri/
https://ebookmass.com/product/ferris-clinical-advisor-2022-1st-
edition-fred-f-ferri/
Cecil Essentials of Medicine 10th Edition Edward J. Wing
Md Facp Fidsa (Editor)
https://ebookmass.com/product/cecil-essentials-of-medicine-10th-
edition-edward-j-wing-md-facp-fidsa-editor/
https://ebookmass.com/product/cecil-essentials-of-medicine-cecil-
medicine-10th-edition-edward-j-wing-md-facp-fidsa-editor/
https://ebookmass.com/product/diagnostic-ultrasound-
musculoskeletal-2nd-edition-james-f-griffith-md-mrcp-frcr-author/
https://ebookmass.com/product/advances-in-ophthalmology-and-
optometry-2021-volume-6-1-advances-volume-6-1-myron-yanoff-md-editor/
CLINICAL DISORDERS Ventricular fibrillation I, III Verrucous lesions II
CARDIOVASCULAR DISEASES SECTION Ventricular tachycardia I Vitiligo I
Acute coronary syndromes I Wolff-Parkinson-White syndrome I Warts I
Aneurysm, abdominal aorta I
Angina pectoris I DERMATOLOGY ENDOCRINOLOGY
Aortic coarctation I Acne vulgaris I Adrenal incidentaloma I, III
Aortic dissection I Actinic keratosis I Adrenal insufficiency I
Aortic regurgitation I Alopecia I Adrenal mass, clinical algorithm III
Aortic stenosis I Angioedema I Adrenocortical hyperfunction II
Arrhythmogenic right ventricular cardiomyopathy I Angular cheilitis I Adrenocortical hypofunction II
Atrial enlargement, left atrium II Atopic dermatitis I Aldosteronism I
Atrial fibrillation I Balanitis I Androgen excess, reproductive-age woman II
Atrial flutter I Basal cell carcinoma I Anhydrosis II
Atrial myxoma I Bedbug bite I Bone density, decreased, generalized II
Atrial septal defect I Calcifications, cutaneous II Bone density, decreased, localized II
Atrium enlargement, right atrium II Candidiasis, cutaneous I Bone mass, low II
Atrioventricular dissociation I Contact dermatitis I Breast, nipple discharge evaluation III
Bicuspid aortic valve I Cutaneous infections, athletes II Calcifications, abdominal, nonvisceral on x-ray II
Branch bundle block I Cutaneous occlusion syndromes III Calcifications, adrenal gland on x-ray II
Bradycardia III Cyanosis, algorithm III Calcifications, genital tract, female on x-ray II
Brugada syndrome I Dermatitis herpetiformis I Calcium stones II
Calcifications, cardiac on x-ray II Discoid lupus I Cushing's disease and syndrome I
Calcifications, valvular on x-ray II Eosinophilic dermatoses III Delayed puberty I
Cardiac death, sudden II Epidermolysis bullosa (EB) I Diabetes insipidus I
Cardiac tamponade I Erosions, genitalia II Diabetes mellitus I
Cardiac tumors II Erysipelas I Diabetic foot I
Cardioembolism II Erythema elevatum diutinum I Diabetic gastroparesis I
Cardiomegaly on chest x-ray III Erythema multiforme I Diabetic ketoacidosis I
Cardiomyopathy, chemical-induced I Erythroderma II Diabetic nephropathy I
Cardiomyopathy, dilated I Eyelid neoplasm II Erectile dysfunction I
Cardiomyopathy, hypertrophic I Fifth disease (parvovirus infection) I Exocrine pancreatic insufficiency (EPI) I
Cardiomyopathy, ischemic, surgical management III Finger lesions, inflammatory II Flushing III
Cardiomyopathy, restrictive I Flushing III Foot lesion, ulcerating II
Cardiorenal syndrome I Folliculitis I Galactorrhea I
Carotid sinus syndrome I Foot dermatitis II Genitourinary syndrome of menopause (GSM) I
Cervical artery dissection I Genital lesions or ulcers III Goiter evaluation and management III
Chronic urticaria I Granuloma, algorithm III Graves disease I
Cirrhotic cardiomyopathy I Granuloma annulare I Gynecomastia I
Congestive heart failure I Granulomatous dermatitides II Hirsutism I
Congestive heart failure and cardiomyopathy II Hand-foot-mouth disease I Hot flashes I
Connective tissue disease–associated I Herpes simplex I Hypercalcemia, clinical algorithm IV
vasculitis Herpes zoster I Hypercalcemia, laboratory differential diagnosis II
Coronary artery disease I Hidradenitis suppurativa I Hypercalcemia, malignancy-induced II
Cor pulmonale I Hyperhydrosis I Hyperlipoproteinemia, primary I
Cyanosis II Hyperpigmentation III Hyperosmolar hyperclycemic syndrome I
Early repolarization syndrome I IgA vasculitis I Hyperostosis, cortical bone II
Ejection sound or click II Impetigo I Hyperparathyroidism I
Giant cell myocarditis I Jaundice, neonatal, algorithm III Hyperthyroidism I
Heart block, second-degree I Kaposi sarcoma I Hypoaldosteronism I
Heart failure, acute I, II Leg ulcer III Hypocalcemia, laboratory differential diagnosis II
Heart failure, pregnancy II Lichen planus I Hypoglycemia II
HIV-associated cardiomyopathy I Lichen sclerosus I Hypogonadism I
Hypercholesterolemia I Lichen simplex chronicus I Hypoparathyroidism I
Hyperlipoproteinemia, primary I Malar eruption III Hypopituitarism I
Hypertension I Mastocytosis I Hypothyroidism I
Hypertension, in children II Melanoma I Infertility I
Hypotension III Melanonychia II Menopause I
Intraventricular conduction defect (IVCD) I Molluscum contagiosum I Metabolic syndrome I
Junctional rhythm I Mucormycosis I Osteoporosis I
Long QT syndrome I Myositis III Osteoporosis, secondary causes II
Mesenteric arterial embolism, associated II Nail dystrophy III Paget disease of the bone I
factors Neurofibromatosis I Pancreatic islet cell tumors III
Mitral regurgitation I Onycholysis III Paraneoplastic syndromes I
Mitral stenosis I Oral hairy leukoplakia I Pheochromocytoma I
Mitral valve prolapse I Panniculitis I Pituitary adenoma I
Multifocal atrial tachycardia I Papulosquamous disorders, pediatric patient III Pituitary region tumors II
Murmur, diastolic III Paronychia I Polycystic ovary syndrome I
Murmur, systolic III Pediculosis I Primary ovarian insufficiency I
Myocardial infarction I Pemphigus vulgaris I Prolactinoma I
Myocarditis I Photosensitivity III Pseudohermaphroditism III
Orthostatic hypotension I Pinworms I Sexual dysfunction III
Palpitations III Pityriasis rosea I Sexual precocity, female breast development III
Paroxysmal supraventricular tachycardia I Porphyrias I Sexual precocity, female pubic hair development III
Patent ductus arteriosus I Premature graying, scalp hair II Sexual precocity, male III
Pericardial effusion, malignant III Pruritus, generalized, clinical algorithm III Short stature III
Pericarditis I Pruritus vulvae II Syndrome of inappropriate antidiuresis I
Pleural effusion, malignant III Psoriasis I Thyroid nodule I
Pleural effusions, malignancy-associated II Purpura, nonpalpable II Thyroid, painful, clinical algorithm III
Postural hypotension, nonneurologic causes II Purpura, non-purpuric disorders simulating II Thyroiditis I
Premature ventricular contractions and II purpura Thyromegaly II
ventricular tachycardia Purpura, palpable II
Pulmonary edema I Purpura, palpable, clinical algorithm III ENVIRONMENTAL MEDICINE
Pulmonary edema, non-cardiogenic II Reactive erythema, pediatric patient III Amebiasis I
Pulseless electrical activity I Rocky Mountain spotted fever I Babesiosis I
Renal artery stenosis I Rosacea I Bite wounds I
Rib notching on x-ray II Roseola I Bites and stings, arachnids I
Short QT syndrome I Scabies I Bites and stings, insect I
Sick sinus syndrome I Scarlet fever I Bites, snake I
Syncope I Scleroderma (systemic sclerosis) I Botulism I
Tachycardia III Skin blisters III Burns I
Tachycardia, narrow complex III Stevens-Johnson syndrome I Contact dermatitis I
Tachycardia, wide complex III Tinea capitis I Diarrhea, acute III
Takayasu's arteritis I Tinea corporis I Drowning I
Takotsubo cardiomyopathy I Tinea cruris I Ehrlichiosis I
Thrombotic microangiopathies, diagnosis III Tinea pedis I Electrical injury I
Torsades des pointes I Tinea versicolor I Envenomation, marine III
Valvular heart disease II Varicella I Food poisoning, bacterial I
Venous ulcers I Venous insufficiency, chronic I Frostbite I
Ventricular septal defect I Venous ulcers I Giardiasis I
Heat exhaustion and heat stroke I Helicobacter pylori infection I Cervicitis I
High-altitude sickness I Hematemesis II Chlamydia genital infections I
Hypothermia I Hemochromatosis I Condyloma acuminatum I
Lyme disease I Hemoperitoneum II Contraception I
Malaria I Hemoptysis I Cystitis, acute III
Microsporidosis I Hepatic encephalopathy I Delayed passage of meconium II
Mushroom poisoning I Hepatitis A I Dysmenorrhea I
Radiation exposure I Hepatitis, acute II Dyspareunia I
Rocky Mountain spotted fever I Hepatitis B I Dysuria and/or urethral/vaginal discharge III
Salmonellosis I Hepatitis B prophylaxis V Eclampsia I
Shigellosis I Hepatitis C I Ectopic pregnancy I
Southern tick-associated rash illness (STARI) I Hepatitis D I Endometrial cancer I
Tapeworm infestation I Hepatitis E I Endometriosis I
Vaccinations for international travel V Hepatitis, viral III Endometritis I
Zika virus I Hepatomegaly, algorithm III Erosions, genitalia II
Hepatomegaly, by shape of liver II Fallopian tube cancer I
GASTROENTEROLOGY Hepatopulmonary syndrome I Fertility preservation in women I
Abdominal compartment syndrome I Hepatorenal syndrome I Fibrocystic breast disease I
Abdominal pain, chronic lower II Hookworm I Genital lesions or ulcers, algorithm III
Abdominal pain, nonsurgical causes II Hypergastrinemia II Genitopelvic pain/penetration syndrome I
Achalasia I Hypersplenism, associated conditions II Gonococcal urethritis I
Acute colonoic pseudo-obstruction I Hypoglycemia II Gonorrhea I
Acute liver failure I Incontinence, fecal II Groin masses II
Acute lower gastrointestinal bleeding I Inguinal hernia I Heart failure, pregnancy II
Acute mesenteric ischemia I Irritable bowel syndrome I Heavy menstrual bleeding I
Alcoholic hepatitis I Ischemia, colon III Hereditary breast and ovarian cancer syndrome I
Anal abscess and fistula II Ischemic colitis I Herpes simplex I
Anorectal fistula I Ischemic hepatitis I Hot flashes I
Anorectal stricture I Jaundice, classification II Hyperemesis gravidarum I
Anorexia II Jaundice in the adult patient I Hypoactive sexual desire disorder I
Aphthous ulcers I Jaundice, neonatal II Hypogonadism III
Appendicitis I Jaundice, neonatal, algorithm III Immunizations during pregnancy V
Ascariasis I Lactose intolerance I Incontinence (urinary) I
Ascites I Large bowel obstruction I Infertility I
Autoimmune hepatitis I Large bowel stricture II Mastitis I
Bacterial overgrowth, small intestine II Levator ani syndrome I Mastodynia I
Barrett esophagus I Liver abscess I Meigs syndrome I
Bile duct, dilated II Liver disease, pregnancy II Menopause I
Bleeding, gastrointestinal, algorithm III Liver lesions, benign II Molar pregnancy I
Bleeding, rectal II Liver transplantation I Nipple lesions II
Bleeding, variceal III Lynch syndrome I Nongonococcal urethritis I
Budd-Chiari syndrome I Malabsorption II Ovarian cancer I
Calcifications, liver on x-ray II Malabsorption algorithm III Ovarian neoplasm, benign I
Calcifications, pancreas on x-ray II Mallory-Weiss tear I Paget's disease of the breast I
Calcifications, spleen on x-ray II Microscopic colitis I Pelvic abscess I
Celiac disease I Nonalcoholic fatty liver disease I Pelvic congestion syndrome I
Cholangiocarcinoma I Non-celiac disease gluten sensitivity I Pelvic inflammatory disease I
Cholangitis I Nutrition assessment and intervention in cancer III Pelvic mass, algorithm III
Cholecystitis I patient Pelvic organ prolapse (uterine prolapse) I
Choledocholithiasis I Odynophagia II Pelvic pain, causes in women II
Cholelithiasis I Pancreas transplantation I Pelvic pain, reproductive-age woman III
Chronic pancreatitis I Pancreatic calcifications II Perirectal abscess I
Cirrhosis I Pancreatic cancer (exocrine) I Placenta previa I
Cirrhosis, primary biliary I Pancreatitis, drug-induced II Polycystic ovary syndrome I
Cirrhotic cardiomyopathy I Peptic ulcer disease I Postpartum depression I
Colic, acute abdominal II Perianal pain II Postpartum hemorrhage I
Colorectal cancer I Peritonitis, secondary I Preeclampsia I
Colostridium difficile infection I Peutz-Jeghers syndrome and other polyposis I Premature rupture of membranes I
Constipation, adult patient II syndromes Premenstrual syndrome I
Constipation I, III Pinworms I Preterm labor I
Crohn disease I Pneumatosis intestinalis in neonate and older child II Primary ovarian insufficiency I
Cryptosporidium infection I Portal hypertension I Pruritus, pregnant patient III
Delayed passage of meconium II Portal vein thrombosis I Pruritus vulvae I, II
Diarrhea, acute III Primary sclerosing cholangitis I Rh incompatibility I
Diarrhea, acute watery and bloody II Rectal mass, palpable II Sexual assault I
Diarrhea, chronic III Retropharyngeal abscess I Sexual dysfunction III
Diarrhea, chronic, in patients with HIV infection, III Shigellosis I Sexual dysfunction in women I, II
algorithm Short bowel syndrome I Spontaneous abortion I
Diarrhea, infectious II Small bowel masses II Syphilis I
Diarrhea, non-infectious II Small bowel obstruction I Thrombocytopenia, in pregnancy II
Diarrhea, persistent I Small bowel intestinal bacterial overgrowth I Toxic shock syndrome I
Diverticular disease (diverticulosis, I Small intestine ulceration II Urinary tract infection I
diverticulitis) Spontaneous bacterial peritonitis I Uterine fibroids I
Drug-induced liver injury I Subphrenic abscess I Uterine malignancy I
Dyspepsia III Tapeworm infestation I Vaginal bleeding during pregnancy I
Dyspepsia, nonulcerative I Toxic megacolon I Vaginal discharge, algorithm III
Dysphagia, oropharyngeal II Traveler's diarrhea I Vaginal fistulas I
Echinococcosis I Ulcerative colitis I Vaginal cancer I
Eosinophilic esophagitis I Vitamin deficiency (hypovitaminosis) I Vaginal prolapse III
Epigastric pain II Vaginitis, estrogen-deficient I
Esophageal tumors I GYNECOLOGY AND OBSTETRICS Vaginitis, fungal I
Esophageal varices I Abruptio placentae I Vaginitis, prepubescent I
Esophagitis II Abnormal uterine bleeding I Vaginitis, Trichomonas I
Familial adenomatous polyps and Gardner I Acute fatty liver of pregnancy I Vaginosis, bacterial I
syndrome Acute pelvic pain in women I
Fetal alcohol spectrum disorder I Adnexal masses I HEMATOLOGY/ONCOLOGY
Food poisoning, bacterial I Amniotic fluid alpha-fetoprotein elevation II Acute lymphoblastic leukemia I
Functional gallbladder disorder I Bartholin gland abscess I Acute myeloid leukemia I
Gallbladder carcinoma I Bleeding, early pregnancy III Anemia, algorithm III
Gastric cancer I Bleeding neonate III Anemia, aplastic I, II
Gastric dilatation II Bleeding, vaginal III Anemia, aplastic due to drugs and chemicals II
Gastric emptying, delayed II Bone mineral density, increased II Anemia, autoimmune hemolytic I
Gastritis I Breast cancer I Anemia, hypochromic II
Gastroenteritis I Breastfeeding difficulties III Anemia, inflammatory I
Gastroesophageal reflux disease I Breast, nipple discharge evaluation III Anemia in newborn III
Giardiasis I Breast, radiologic evaluation III Anemia, iron deficiency I
Gilbert disease I Breast, routine screen or palpable mass evaluation III Anemia, macrocytic III
Glossitis I Cervical cancer I Anemia, microcytic III
Glossodynia II Cervical dysplasia I Anemia, pernicious I
Anemia with reticulocytosis III Pancytopenia II Endometritis I
Anorexia-cachexia syndrome associated with I Paraneoplastic neurologic syndromes II Epididymitis I
malignancy Pericardial effusion, malignant III Epidural abscess I
Antiphospholipid antibody syndrome I Pheochromocytoma I Epiglottitis I
Astrocytoma I Pigmenturia II Epstein-Barr virus infection I
Atypical lymphocytosis, heterophil negative, II Pituitary adenoma I Erysipelas I
infectious causes Pituitary region tumors II Esophagitis II
Basal cell carcinoma I Pleural effusion, malignant III Fever and infection in high-risk patient without III
Bladder cancer I Pleural effusions, malignancy-associated II obvious source
Bleeding, congenital disorder III Polycythemia II Fever and neutropenia, pediatric patient III
Bleeding neonate III Polycythemia, algorithm III Fever in the returning traveler I
Bleeding time (modified Ivy method) IV Polycythemia, relative versus absolute II Fever of undetermined origin I
Bone marrow failure syndromes, inherited II Polycythemia vera I Fifth disease (parvovirus infection) I
Bone tumor, primary malignant I Postthrombotic syndrome I Folliculitis I
Brain metastases I Prolactinoma I Food poisoning, bacterial I
Brain neoplasm I Prostate cancer I Foot lesion, ulcerating II
Brain neoplasm, benign I Pulmonary infiltrates, immunocompromised host II Genital lesions or ulcers III
Brain neoplasm, glioblastoma I Purpura, nonpalpable II Giardiasis I
Breast cancer I Purpura, non-purpuric disorders simulating II Gonococcal urethritis I
Cancer of unknown primary site I purpura Granulomatous dermatitides II
Cervical cancer I Purpura, palpable II Groin masses II
Chemotherapy-induced nausea and vomiting I Renal cell adenocarcinoma I Hand-foot-mouth disease I
Cholangiocarcinoma I Reticulocyte count IV Helicobacter pylori infection I
Chronic lymphocytic leukemia I Retinoblastoma I Hepatitis A I
Chronic myeloid leukemia I Rh incompatibility I Hepatitis, acute II
Chylothorax II Salivary gland neoplasms I Hepatitis B I
Cobalamin deficiency II Sickle cell disease I Hepatitis C I
Colorectal cancer I Spine tumor III Hepatitis D I
Conjunctival neoplasm II Splenomegaly, algorithm III Hepatitis E I
Cryoglobulinemia I Splenomegaly and hepatomegaly II Hepatitis, viral III
Deep vein thrombosis I Splenomegaly, children II Herpes simplex I
Disseminated intravascular coagulation I Squamous cell carcinoma I Herpes simplex keratitis I
Endometrial cancer I Superior vena cava syndrome I Herpes zoster I
Erythrocytosis II Testicular cancer I HIV-associated cardiomyopathy I
Erythrocytosis, acquired III Thalassemias I Histoplasmosis I
Esophageal tumors I Thrombocytopenia, differential diagnosis II HIV cognitive dysfunction I
Eyelid neoplasm II Thrombocytopenia, inherited disorders II HIV: Recommended immunization schedule for V
Fallopian tube cancer I Thrombocytopenia, in pregnancy II HIV-infected children
Fetal alcohol spectrum disorder I Thrombocytosis I Hookworm I
Fever and neutropenia, pediatric patient III Thrombosis or thrombotic diathesis II Human immunodeficiency virus I
Fever, non-infectious causes II Thrombotic thrombocytopenic purpura I Impetigo I
Folate deficiency II Thyroid carcinoma I Immunization schedule, childhood, accelerated V
Gallbladder carcinoma I Transfusion reaction, hemolytic I if necessary for travel
Gastric cancer I Tumor lysis syndrome I Immunization schedule, childhood and V
Graft-versus-host disease (GVHD) I Tumor markers elevation II adolescence
Groin masses II Upper extremity deep vein thrombosis I Immunization schedule, contraindications and V
Head and neck squamous cell carcinoma I Uterine malignancy I precautions
Hemolysis, mechanical II Vaginal cancer I Immunization schedule, HIV-infected children V
Hemolytic-uremic syndrome I Von Willebrand disease I Immunizations for adults V
Hemophilia I Waldenström macroglobulinemia I Immunizations during pregnancy V
Hemoptysis I Immunizations for immunocompromised infants V
Heparin-induced thrombocytopenia I INFECTIOUS DISEASES and children
Hepatocellular carcinoma I Acquired immunodeficiency syndrome I Immunizing agents and immunization schedules V
Hereditary breast and ovarian cancer syndrome I Acute bronchitis I for health-care workers
Hodgkin lymphoma I Amebiasis I Influenza I
Hypercalcemia, malignancy-induced II Anaerobic infections I Ischemic hepatitis I
Hypercoagulable state I Anal abscess and fistula II Kaposi sarcoma I
Hypercoagulable state, associated disorders II Ascariasis I Laryngitis I
Hypersplenism I Aspergillosis I Laryngotracheobronchitis I
Hypersplenism, associated conditions II Aspiration, oral contents III Legionnaires' disease I
Immune thrombocytopenic purpura I Aspiration pneumonia I Lemierre syndrome I
Intraocular neoplasm II Atypical lymphocytosis, heterophil negative, II Listeriosis I
Iron overload II infectious causes Liver abscess I
Kaposi sarcoma I Babesiosis I Lung abscess I
Lead poisoning I Bacterial overgrowth, small intestine II Lyme disease I
Liver lesions, benign II Bacterial pneumonia I Lymphangitis I
Lung cancer, occupational causes II Balanitis I Lymphocytosis, atypical II
Lung neoplasms, primary I Bartholin gland abscess I Malaria I
Lymphadenopathy, generalized, algorithm III Bedbug bite I Mastoiditis I
Lymphocytes IV Bite wounds I Mediastinitis I
Lymphocytosis, atypical II Botulism I Mediastinitis, acute II
Macrothrombocytopenia, inherited II Brain abscess I Meningitis, bacterial I
Medical marijuana I Breast abscess I Meningitis, viral I
Meigs syndrome I Candidiasis, cutaneous I Meningitis, recurrent II
Melanoma I Candidiasis, invasive I Mesenteric adenitis I
Meningioma I Cat-scratch disease I Methicillin resistant Staphylococcus aureus (MRSA) I
Mesothelioma, malignant I Cavernous sinus thrombosis I Microsporidiosis I
Microangiopathic hemolytic anemia I Cellulitis I Middle East respiratory syndrome I
Monoclonal gammopathy of renal significance I Cervicitis I Molluscum contagiosum I
(MGRS) Childhood and adolescent immunizations V Mononucleosis I
Monoclonal gammopathy of undetermined I Chlamydia genital infections I Mononucleosis, monospot negative II
significance Cholangitis I Mucormycosis I
Monocytosis II Cholecystitis I Multidrug-resistant gram-negative rods I
Mononucleosis, monospot negative II Clostridium difficile infection I (MRD-GNRs)
Multiple endocrine neoplasia I Colorado tick fever I Mumps I
Multiple myeloma I Condyloma acuminatum I Necrotizing fasciitis I
Myelodysplastic syndrome I Conjunctivitis I Necrotizing pneumonias II
Nasopharyngeal carcinoma I Cryptococcosis I Nongonococcal urethritis I
Neutropenia II Cryptosporidium infection I Orchitis I
Neutropenia with decreased marrow reserve II Cysticercosis I Osteomyelitis I
Neutrophilia II Cytomegalovirus infection I Otitis externa I
Non-Hodgkin lymphoma I Diarrhea, infectious II Otitis media I
Nutrition assessment and intervention in cancer III Ear pain III Paronychia I
patient Echinococcosis I Pediculosis I
Ovarian cancer I Ehrlichiosis I Pelvic abscess I
Ovarian neoplasm, benign I Empyema I Pelvic inflammatory disease I
Paget's disease of the breast I Encephalitis, acute viral I Perirectal abscess I
Pancreatic cancer (exocrine) I Endocarditis, infective I Peritonitis, secondary I
Pancreatic islet cell tumors III Endocarditis prophylaxis V Pertussis I
Pharyngitis/tonsillitis I Calcium stones II Convulsive disorder, pediatric age III
Pinworms I Cardiorenal syndrome I Daytime sleepiness II
Pneumonia, mycoplasma I Chronic kidney disease I Delirium I
Pneumonia, pnuemocystis jiroveci I Contrast-associated acute kidney injury I Delirium, agitated II
Pneumonia, viral I Dehydration correction, pediatric patient III Delirium, dialysis patient II
Prostatitis I Edema, generalized, algorithm III Dementia, algorithm III
Pyelonephritis I End-stage kidney disease I Dementia with Lewy bodies I
Reactive arthritis I Glomerulonephritis, rapidly progressive II Diabetic polyneuropathy I
Renal abscess l Glomerulopathies, thrombotic, microangiopathic II Dilated pupil III
Rocky Mountain spotted fever I Glomerulosclerosis, focal segmental II Diplopia, monocular II
Roseola I Goodpasture syndrome I Diplopia, vertical II
Salmonellosis I Hematuria, in children II Dissociative disorders I
Scabies I Hemolytic-uremic syndrome I Dizziness II
Scarlet fever I Hepatorenal syndrome I Dystonia I
Sepsis I Hydronephrosis I Elbow pain II
Septic arthritis I Hypercalcemia, algorithm IV Encephalomyelitis, nonviral causes II
Shigellosis I Hyperkalemia I Encephalopathy I
Sialadenitis I Hypermagnesemia, algorithm IV Epidural abscess I
Sinusitis I Hypernatremia, algorithm IV Epidural hematoma I
Sore throat II Hyperuricemia I Esotropia II
Southern tick-associated rash illness (STARI) I Hypocalcemia, laboratory differential diagnosis II Essential tremor I
Spinal epidural abscess I Hypokalemia, algorithm IV Febrile seizures I
Spontaneous bacterial peritonitis I Hypokalemia, differential diagnosis II Focal seizures I
Stomatitis I Hypokalemic periodic paralysis I Footdrop II
Stye (hordeolum) I Hypomagnesemia I Frontotemporal dementia I
Syphilis I Hypomagnesemia, algorithm IV Generalized tonic-clonic seizures I
Tapeworm infestation I Hypomagnesemia, differential diagnosis II Guillain-Barré syndrome I
Thrombophlebitis, superficial I Hyponatremia I, II Hallucinogenic overdose I
Tinea corporis I Hypoparathyroidism I Headache, acute II
Tinea cruris I Hypophosphatemia, algorithm IV Headache, chronic II
Tinea unguium I IgA nephropathy I Hearing loss, algorithm III
Tinea versicolor I Interstitial nephritis I Hereditary neuropathy I
Toxoplasmosis I Kidney enlargement, unilateral II HIV cognitive dysfunction I
Tuberculosis, miliary I Microscopic polyangiits I Horner syndrome I
Tuberculosis, pulmonary I Monoclonal gammopathy of renal significance I Huntington chorea I
Urinary tract infection I (MGRS) Hydrocephalus, normal pressure I
Urosepsis II Nephrocalcinosis II Inclusion body myositis I
Vaccinations for international travel V Nephrotic syndrome I Inflammatory myopathies I
Vaccinations, recommendations for persons V Oliguria, algorithm III Intracerebral hemorrhage, nonhypertensive II
with medical conditions Pigmenturia II causes
Vaginitis, fungal I Pyelonephritis I Labyrinthitis I
Vaginitis, Trichomonas I Relapsing polychondritis I Leg movement when standing, involuntary II
Vancomycin resistant Enterococcus (VRE) I Renal abscess I Leptomeningeal lesions II
Varicella I Renal artery stenosis I Memory loss symptoms, elderly patients II
Viral bronchiolitis I Renal cell adenocarcinoma I Meniere disease I
Zika virus I Renal cystic disorders II Meningioma I
Renal disease, ischemic management III Mental status changes and coma II
MISCELLANEOUS Renal failure, acute, pigment-induced II Migraine headache I
Abdominal wall masses II Renal mass III Mild cognitive impairment I
Anaphylaxis I Renal parenchymal disease, chronic II Mononeuropathies, isolated II
Anorexia II Renal tubular acidosis I Motion sickness I
Cyanosis II Renal vein thrombosis I Multiple sclerosis I
Deep vein thrombosis I Rhabdomyolysis I Muscle disease II
Dehydration correction, pediatric patient III Scombroid poisoning I Muscle weakness, algorithm III
Delayed passage of meconium II Statin-induced muscle syndromes I Muscular dystrophy I
Drowning I Tension-type headache l Myasthenia gravis I
Familial Mediterranean Fever I Tumor lysis syndrome I Myelin disorders II
Fever, non-infectious causes II Uric acid stones II Myoclonus I
Food allergies I Urinary retention II Myotonia I
Graft-versus-host disease (GVHD) I Urine color abnormalities II Narcolepsy I
Groin lump II Urolithiasis I Neurocognitive disorders I
Hallucinogenic overdose I Neuromuscular junction dysfunction II
Iliac fossa pain, left sided II NEUROLOGY Neuronopathies, sensory (ganglionopathies) II
Iliac fossa pain, right sided II Absence seizures I Neuropathic bladder II
Lactic acidosis I Acoustic neuroma I Neuropathic pain I
Malignant hyperthermia I Alzheimer's disease I Neuropathies, peripheral, asymmetrical II
Mediastinitis I Amaurosis fugax I proximal/distal
Mediastinal compartments, anatomy and II Amblyopia I Neuropathies with facial nerve involvement II
pathology Amyotrophic lateral sclerosis I New onset seizures I
Medical marijuana I Anisocoria III Nystagmus, monocular II
Methanol and ethylene glycol poisoning I Anoxic brain injury I Opsoclonus II
Opioid overdose I Antibody-mediated autoimmune encephalitis I Optic atrophy II
Opioid use disorder I Astrocytoma I Optic neuritis I
Paralytic shellfish poisoning I Ataxia, acute or recurrent II Osteosclerosis, diffuse II
Paraneoplastic syndromes I Ataxia, cerebellar, adult onset II Paraneoplastic neurologic syndromes II
Pleurisy I Ataxia, cerebellar, children II Paraparesis, acute or subacute II
Postthrombotic syndrome I Ataxia, chronic or progressive II Paraparesis, chronic progressive II
Sarcoma I Ataxia, progressive III Parkinsonism-plus syndromes II
Shift work disorder I Autistic spectrum disorders I Parkinson disease I
Sore throat II AV malformations, cerebral I Periodic limb movement disorder I
Statin-induced muscle syndromes I Ballism II Polyneuropathies, demyelinating II
Substance use disorder I Bell palsy I Polyneuropathies, distal, sensorimotor II
Synthetic cannabinoids I Benign paroxysmal positional vertigo I Postconcussive syndrome I
Tracheobronchial narrowing on x-ray II Blindness, monocular, transient II Postherpetic neuralgia I
Upper extremity deep vein thrombosis I Brain neoplasm I Primary angiitis of the central nervous system I
Vitamin D deficiency I Brain neoplasm, benign I Ramsay Hunt syndrome I
Vitamin deficiency (hypovitaminosis) I Brain neoplasm, glioblastoma I Restless legs syndrome I
Carotid artery stenosis I Sciatica I
NEPHROLOGY Carpal tunnel syndrome I Seizures, mimics II
Acid-base homeostasis III Cerebral infarction secondary to inherited II Shaken baby syndrome I
Acidosis, metabolic, algorithm III disorders Smell disturbance II
Acute glomerulonephritis I Cerebrospinal fluid (CSF) IV Spasticity I
Acute kidney injury I Charcot-Marie-Tooth disease I Spinal cord compression I
Acute tubular necrosis I Chronic inflammatory demyelinating I Spinal cord compression, epidural II
Acute urinary retention (AUR) I polyneuropathy Spinal cord dysfunction, non-traumatic II
Alkalosis, metabolic, algorithm III Chronic traumatic encephalopathy (CTE) I Spinal cord ischemic syndromes II
Autosomal dominant polycystic kidney disease I Cluster headache I Spinal stenosis I
AV malformations, cerebral I Complex regional pain syndrome I Status epilepticus I
Calcium-alkali syndrome I Concussion I Stroke, acute ischemic I
2021
Ferri’s
CLINICAL
ADVISOR
FRED F. FERRI, MD, FACP
Clinical Professor
Department of Medicine
Warren Alpert Medical School
Brown University
Providence, Rhode Island
Elsevier
1600 John F. Kennedy Blvd.
Ste 1800
Philadelphia, PA 19103-2899
No part of this publication may be reproduced or transmitted in any form or by any means, electronic or
mechanical, including photocopying, recording, or any information storage and retrieval system, without
permission in writing from the publisher. Details on how to seek permission, further information about the
Publisher's permissions policies and our arrangements with organizations such as the Copyright Clearance
Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the Publisher
(other than as may be noted herein).
Notice
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and
using any information, methods, compounds or experiments described herein. Because of rapid advances
in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be
made. To the fullest extent of the law, no responsibility is assumed by Elsevier, authors, editors or con-
tributors for any injury and/or damage to persons or property as a matter of products liability, negligence
or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in
the material herein.
ISBN: 978-0-323-71333-7
iii
iv Section Editors
Bharti Rathore, MD Iris L. Tong, MD
Program Director, Hematology/ Associate Professor
Oncology Fellowship Department of Medicine
Roger Williams Medical Center Warren Alpert Medical School of
Providence, Rhode Island; Brown University;
Assistant Professor of Medicine Attending Physician
Boston University School of Women’s Primary Care
Medicine Women’s Medicine Collaborative
Boston, Massachusetts Providence, Rhode Island
Maheswara Satya Gangadhara Rao Golla, MD Priya Sarin Gupta, MD, MPH
Department of Cardiovascular Medicine Adolescent Medicine Fellow
Steward Family Hospital, St. Elizabeth’s Medical Center Division of General Pediatrics and Adolescent Medicine
Brighton, Massachusetts Johns Hopkins Hospital
Baltimore, Maryland
Caroline Golski, MD
Resident Physician Nawaz K. A. Hack, MD
General Psychiatry Assistant Professor of Neurology
Warren Alpert Medical School of Brown University F. Edward Hébert School of Medicine
Providence, Rhode Island Uniformed Services University of the Health Sciences
Bethesda, Maryland
Helen B. Gomez, MD
Resident Physician Moti Haim, MD
Obstetrics and Gynecology Director, Cardiac Electrophysiology and Pacing
Christiana Care Health System Soroka Medical Center
Newark, Delaware Ben Gurion University of the Negev
Be’er-Sheva, Israel
Avi D. Goodman, MD
Orthopedic Trauma Fellow Sajeev Handa, MD, SFHM
Department of Orthopedics Chief, Hospital Medicine
Warren Alpert Medical School of Brown University Lifespan Physician Group
Providence, Rhode Island Rhode Island, Miriam, and Newport Hospitals
Clinical Assistant Professor of Medicine and Neurology
Paul Gordon, MD Warren Alpert Medical School of Brown University
Clinical Assistant Professor of Medicine Providence, Rhode Island
Division of Cardiology
Warren Alpert Medical School of Brown University M. Owais Hanif, MD
Providence, Rhode Island Senior Nephrology Fellow
Hahnemann Hospital
John A. Gray, MD, PhD Philadelphia, Pennsylvania
Assistant Professor
Department of Neurology Nikolas Harbord, MD
Center for Neuroscience Division Chief, Nephrology and Hypertension
University of California, Davis Mount Sinai Beth Israel
Davis, California Assistant Professor
Icahn School of Medicine at Mount Sinai
Simon Gringut, MD New York, New York
Cardiac Electrophysiology Fellow
Yale New Haven Hospital Sonali Harchandani, MD
New Haven, Connecticut Fellow
Hematology/Oncology
Lauren Grocott, BA University of Massachusetts Medical School
Clinical Research Assistant Worcester, Massachusetts
Rhode Island Hospital
Providence, Rhode Island Erica Hardy, MD, MMS
Director of Women’s Infectious Disease
Stephen L. Grupke, MD, MS Division of Infectious Disease and Obstetric Medicine
Assistant Professor Women and Infants Hospital
Department of Neurosurgery Providence, Rhode Island
University of Kentucky
Lexington, Kentucky
Contributors xiii
Daniel Brian Carlin Reid, MD, MPH Gregory Rochu, MD, MPH
Resident Physician Assistant Professor of Medicine
Warren Alpert Medical School of Brown University Division of Geriatrics and Palliative Medicine
Rhode Island Hospital Warren Alpert Medical School of Brown University
Providence, Rhode Island Providence, Rhode Island
Talia Zenlea, MD
Assistant Professor of Medicine
Division of Gastroenterology
University of Toronto
Women’s College Hospital
Toronto, Ontario, Canada
To my sons, Dr. Vito F. Ferri and Dr. Christopher A. Ferri, and my daughter-in-law,
Dr. Heather A. Ferri, for their help and constant support, and to my wife, Christina, for her
patience during manuscript preparation. A special thanks to all the readers who have
personally commented on the merits of this book and through their suggestions have helped
make this product a bestseller in the medical field.
This book is intended to be a clear and concise reference for physicians and abnormal results, this section facilitates the diagnosis of medical disorders
allied health professionals. Its user-friendly format is designed to provide and further adds to the comprehensive “one-stop” nature of our text. New
a fast and efficient way to identify important clinical information and to illustrations and tables have been added for this edition.
offer practical guidance in patient management. The book is divided into Section V focuses on preventive medicine. Information here includes
five sections and an appendix, each with emphasis on clinical information. screening recommendations for major diseases and disorders, patient
The tremendous success of the previous editions and the enthusiastic counseling, and immunization and chemoprophylaxis recommendations.
comments from numerous colleagues have brought about several positive The Appendix is divided into nine major sections. Appendix I con-
changes over time. Each section has been significantly expanded from tains extensive information on complementary and alternative medicine
prior editions, bringing the total number of medical topics covered in this (CAM), now expanded to include Common Herbs in Integrated Medicine,
book to more than 1200. Hundreds of new illustrations, tables, and boxes as well as Herbal Activities Against Pain and Chronic Diseases. With this
have been added to this edition to enhance recollection of clinically impor- material, we aim to lessen the current scarcity of exposure of allopathic
tant facts. The expedited claims submission and reimbursement ICD-10CM and osteopathic physicians to the diversity of CAM therapies. Appendix
codes are included in all topics. II focuses on nutrition, with an emphasis on dietary supplements, vita-
Section I describes in detail 988 medical disorders and diseases— mins, and minerals. Appendix III deals with diagnosis and treatment of
including 25 new topics this edition—arranged alphabetically and pre- acute poisoning. Appendix IV is a guide on impairment and disability
sented in outline format for ease of retrieval. Topics with an accompanying evaluation. Appendix V focuses on the protection of travelers. Appendix
algorithm are identified with an ALG icon. Similarly, those topics with an VI addresses Physician Quality Reporting System (PQRS) measures.
accompanying online Patient Teaching Guide (PTG) are identified with a Appendix VII—available in the online version of Ferri’s Clinical Advisor—
PTG symbol. Throughout the text, key quick-access information is consis- is a repository of practical patient instruction sheets, organized alpha-
tently highlighted, with clinical photographs to further illustrate selected betically and covers the majority of topics in this book. These guides
medical conditions, and relevant ICD-10CM codes listed. Most references can be easily customized and printed and serve as valuable tools for
focus on current peer-reviewed journal articles rather than outdated text- improving physician-patient communication, patient satisfaction, and
books and old review articles. ultimately quality of care. Appendix VIII and IX are both new to this edition
Topics in Section I use the following structured approach: and offer guidance related to palliative care and preoperative evaluation,
1. Basic Information (Definition, Synonyms, ICD-10CM Codes, Epidemiol- respectively.
ogy & Demographics, Physical Findings & Clinical Presentation, Etiology) I believe that we have produced a state-of-the-art information system
2. Diagnosis (Differential Diagnosis, Workup, Laboratory Tests, Imaging with significant differences from existing texts. The information offered
Studies) in all five sections and patient education guides could be sold separately
3. Treatment (Nonpharmacologic Therapy, Acute General Rx, Chronic Rx, based on their content, yet are available under a single cover, offering the
Disposition, Referral) reader tremendous value. I hope that the Clinical Advisor’s user-friendly
4. Pearls & Considerations (Comments, Suggested Readings) approach, numerous unique features, and yearly updates will make this
Section II includes the differential diagnosis, etiology, and classification book a valuable medical reference, not only to primary care physicians but
of signs and symptoms. This practical section allows the user investigating also to physicians in other specialties, medical students, and allied health
a physical complaint or abnormal laboratory value to follow a “workup” professionals.
leading to a diagnosis. The physician can then easily look up the presump-
tive diagnosis in Section I for information specific to that illness. Fred F. Ferri, MD, FACP
Section III includes more than 150 clinical algorithms to guide and Clinical Professor
expedite the patient’s workup and therapy. For the 2021 edition, we have Department of Medicine
continued to update algorithms and colorize online versions for improved Warren Alpert Medical School of Brown University
readability. Physicians describe this section as particularly valuable in Providence, Rhode Island
today’s managed-care environment.
Section IV includes normal laboratory values and interpretation of Note: Comments from readers are always appreciated and can be for-
results of commonly ordered laboratory tests. By providing interpretation of warded directly to Dr. Ferri at [email protected].
xxix
Ferri’s Clinical Advisor 2021—How to Use This Book
xxx
Abdominal Aortic Aneurysm 3
and Disorders
Diseases
ered aneurysmal. develop an AAA have smoked at some and has determined that men over the age
point in their lives. of 75 are unlikely to benefit from screen-
ICD-10CM CODES 2. Inherited: Familial clusters are common. ing. It was also concluded that the current
I71.4 Abdominal aortic aneurysm, without High familial prevalence rate is notable evidence is insufficient to assess the balance
rupture in male individuals. The nature of the of the harms and benefits of screening for
I71.3 Abdominal aortic aneurysm, ruptured genetic disorder is unclear but may be AAA in women ages 65 to 75 who have ever
linked to alpha-1-antitrypsin deficiency smoked.
I
EPIDEMIOLOGY & disorders, such as Marfan syndrome and
DEMOGRAPHICS scan should be performed every 6 months
strongly associated with AAA. for patients with AAAs measuring 5.0 to 5.4
States are attributed to AAA. 3. Inflammatory: AAA is a progressive cm in diameter, every 12 months for AAAs
inflammatory disease of the artery walls.
adults, affecting men more than women (4:1). Activated B lymphocytes promote AAA by
producing immunoglobulins, cytokines,
men in developed countries. and matrix metalloproteinases (MMPs), PHYSICAL FINDINGS & CLINICAL
≥4 cm are present resulting in the activation of macro- PRESENTATION
in 1% of men between age 55 and 64; and -
the prevalence rate increases by 2% to 4% ment pathways that lead to the degrada- incidentally discovered on imaging studies;
per decade thereafter. tion of collagen and matrix proteins and however, symptomatic aneurysms are at an
- to aortic wall remodeling. increased risk for rupture.
mately 70 yr old. 4. Infection, mycotic: Syphilis, Salmonella.
-
ers than in nonsmokers (8:1); and the risk NATURAL HISTORY
decreases with smoking cessation. physical examination is markedly diminished
and to expand, on average, at a rate of 0.2 to by obese body habitus.
for other atherosclerotic cardiovascular 0.5 cm per yr.
abdominal, back, flank, or groin pain.
race, smoking, male gender, family history, influenced by aneurysm size, rate of expan-
hypertension, hyperlipidemia, peripheral sion, and sex. Other factors associated with not be tender may be present
vascular disease, and aneurysm of other increased risk for rupture include continued
large vessels. smoking, uncontrolled hypertension, and renal or visceral arterial stenosis.
increased wall stress.
first-degree male relatives of known AAA -
patients. (together with histopathologic changes such rants. In addition, prominent femoral and
as accumulation of foam cells, cholesterol popliteal pulses warrant an abdominal ultra-
crystals, and matrix metalloproteinases) ren- sound and lower extremity ultrasound.
diabetes. ders the abdominal aortic wall more suscep-
caused by compression of adjacent bowel.
men age 65 or older.
is 25% to 40% for aneurysms >5.0 cm in occur from iliocaval venous compression.
death in men older than age 55. diameter, 1% to 7% for AAAs 4.0 to 5.0
cm, and nearly 0% for AAAs <4.0 cm. The extremity pain and discoloration.
likelihood that an aneurysm will rupture is
or renal transplants, severe obstructive increased in aneurysms with a diameter >5.5 cause flank and groin pain and lead to
lung disease, uncontrolled blood pres- cm; this size also demonstrates a faster rate obstructive renal failure.
sure, female sex, and ongoing tobacco of expansion (>0.5 cm over 6 months) and is
use. more likely to be found in those who continue abdominal or back pain, hypotension, and
to smoke and in females. a pulsatile abdominal mass in 50% of
of AAA and related mortality has been attrib- patients.
uted to reductions in tobacco use. However,
hospital in time for surgical repair. Of those infarction; arteriovenous fistulas may present
thoracic aortic aneurysms. who reach the hospital, the mortality rate is still as heart failure; aortoenteric fistulas may
50%, compared with the 1% to 4% mortality present as hematemesis or melena associ-
rate for elective repair of a nonruptured AAA. ated with abdominal and back pain.
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
4 Abdominal Aortic Aneurysm
Symptoms of AAA: pulsatile mass; abdominal pain radiating to back, flank, groin;
peripheral emboli; flank and/or groin pain; melena thought to be due to
RA IN
aortoenteric fistula; syncope; flank mass or discoloration; lower-extremity paralysis cm
LK
RK
Vital signs, intravenous access via 2 large-bore catheters, oxygen, complete An
blood count, serum chemistry panel, liver function panel, type and cross-match
for 6 units of blood, urinalysis, prothrombin/partial thromboplastin time,
electrocardiogram, portable chest radiograph
CIA
IIA
Unstable: low BP, tachycardia, ill-appearing Stable, but concern
for AAA EIA
DIAGNOSIS
Aorta well Stabilized
visualized and and no clear AAA DIFFERENTIAL DIAGNOSIS
no sign of aneurysm or
aneurysm doubt as to Almost 75% of patients with AAA are asymp-
diagnosis tomatic, and the condition is discovered on
routine examination or serendipitously when
ordering studies for other symptoms. Diagnosis
Surgery Surgery of AAA should be considered in the differential
consultation consultation of the following symptoms: abdominal pain,
for operative repair
The differential diagnosis includes peptic ulcer
disease, mesenteric ischemia, renal calculi,
Consider spiral CT pyelonephritis, and diverticulitis.
LABORATORY TESTS
Consider alternative diagnosis:
musculoskeletal back pain, diverticulitis, cholecystitis, Not routinely indicated. For suspected infected
appendicitis, renal colic, pancreatitis, intestinal
ischemia, bowel obstruction, myocardial infarction; blood cultures can be considered. An elevated
epidural abscess or vertebral osteomyelitis, aortic D-dimer may indicate a thrombus within the
dissection, cauda equina aneurysm. Fig. 1 describes an algorithm for the
diagnosis and treatment of abdominal aortic
FIG. 1 Algorithm for the diagnosis and treatment of abdominal aortic aneurysms (AAAs). BP, Blood aneurysms.
pressure; CT, computed tomography; MRI, magnetic resonance imaging; NS, normal saline; PRBCs, packed
red blood cells; SBP, systolic blood pressure; US, Emergency medicine, IMAGING STUDIES
clinical essentials Fig. 2) has nearly
100% sensitivity and specificity in identify-
ing an aneurysm and estimating the size to
within 0.3 to 0.4 cm. It is not accurate in
EPI estimating the extension to the renal arteries
or the iliac arteries.
FIG. 2 Transverse image of an abdomi- Fig. 3) scan is
nal aortic aneurysm. Note the measure- recommended for preoperative aneurysm
imaging and estimates the size of the AAA to
cava is seen to the patient’s right of the within 0.3 mm. There are no false-negative
aorta, and the vertebral body is seen below results, and the scan can identify extension to
the two vessels. Note also that there appears renal vessels with more precision than ultra-
to be an echogenic flap within the aorta, sound. It is the imaging modality of choice for
possibly representing an aortic dissection. symptomatic AAA. Intravenous contrast is not
Emergency medicine,
3.33cm clinical essentials, ed 2, Philadelphia, 2013,
3.85cm wall (Fig. 4) and exclude rupture.
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
Abdominal Aortic Aneurysm 5
-
prospective studies and meta-analyses, the
detection and characterization of endoleaks
tional method of treatment. However, multiple
trials have shown lower mortality and shorter A
an aneurysm in calcified aortas. This is an
insensitive test for diagnosing AAA. imaging. increasingly using endovascular repair for
patients who fit certain anatomic and physi-
replaced by other noninvasive imaging ologic criteria.
TREATMENT
Intraoperative angiography is still used for
determining treatment options and post- NONPHARMACOLOGIC THERAPY versus open repair for ruptured abdominal
procedure efficacy (Fig. 5). aortic aneurysm failed to show a difference
in expansion rate through treatment of cardi-
close and lifelong imaging surveillance of ac risk factors, nonpharmacologic treatment open repair. There was a higher incidence of
and Disorders
Diseases
the aneurysm site for the timely detection of continues to focus on risk factor modification
possible complications, including endoleaks, (most importantly smoking cessation, diet, although interventions to deal with procedur-
graft migration, fractures, graft infection, and and exercise). Of note, moderate exercise al complications were generally less invasive
enlargement of aneurysm sac size with even- does not increase the rate of aneurysm and involved catheter-based approaches.
tual rupture. The rate of complications after expansion or the risk of rupture. -
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
6 Abdominal Aortic Aneurysm
-
specifically those with coronary artery dis- onstrate no advantage to immediate repair
endoleak, stent migration, change in aneu- ease or those with more than one clinical for small AAA (4.0 to 5.5 cm), regardless of
rysm size, and need for re-intervention. risk factor based on the American Heart whether open or endovascular repair is used
Association (AHA) guidelines, preoperative and, at least for open repair, regardless of
an alternative to open repair in the manage- administration of beta-blockers titrated to a patient age and AAA diameter. Thus, neither
ment of juxtarenal aortic aneurysms and goal heart rate of 60 have been shown to immediate open nor immediate endovascular
short-neck abdominal aortic aneurysms (the decrease incidence of death from cardiac repair of small AAAs is supported by the cur-
causes or nonfatal myocardial infarctions. rently available evidence.
renal artery to the beginning of the aneu- Beta-blockers initiated within 24 hours of -
the procedure have not shown an advantage; tive AAA repair despite advances in short-
safe and efficacious treatment, particularly however beta-blockers the patient is already term outcomes and is associated with AAA
for those deemed surgically high risk. taking should be continued. diameter and patient age at the time of
- -
to improve the life expectancy of patients
is associated with lower 30-day mortal- major clinical complications, particularly if with repaired AAA and to optimize patient
ity and MI rates, shorter hospital stays, and selection.
present in conjunction with cardiac or renal
disease. Smoking cessation for 2 months COMMENTS
has increased rates of graft-related com- before surgery has also been shown to
plications and is more costly. Additionally, decrease pulmonary morbidity. be due in part to decreased lamellar struc-
tural proteins in the vascular wall below the
mortality, showing up to as high as 41% renal arteries leading to decreased vascular
higher all-cause mortality, reintervention, and mortality in those with impaired renal func- wall strength.
tion compared with 6% in those without renal
dysfunction. coexisting coronary artery disease, pul-
reintervention and secondary rupture rates. monary disease, or chronic renal failure.
- REFERRAL
perioperative hemodynamic monitoring help
and approximately half of all early endoleaks asymptomatic patients with AAAs that are identify high-risk patients and decrease post-
resolve spontaneously within a period of 30 approximately 4.5 cm. operative complications.
days.
- over 6 months, it is reasonable to offer repair,
ferred approach for patients with a long life although small studies have shown that
expectancy. using expansion as a criterion for surgical
referral is of unclear benefit.
approach for most patients with a reasonable - SUGGESTED READINGS
life expectancy and suitable anatomy. ditions before surgical referral. Available at
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
Abdominal Aortic Aneurysm 6.e1
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
6.e2 Abdominal Compartment Syndrome
among whom it ranges from 1% to 14%, PHYSICAL FINDINGS & CLINICAL
BASIC INFORMATION depending on the population and type of trauma PRESENTATION
studied. The incidence is the highest among -
DEFINITION critically ill patients. ing is often massive abdominal distention.
Abdominal compartment syndrome (ACS) is RISK FACTORS: The biggest risk factor for
defined by the presence of organ dysfunction developing ACS is critical illness stemming from and decreased urine output are also typical
as a result of increased abdominal pressure a wide array of medical and surgical conditions hallmarks.
or intraabdominal hypertension. The increased (Table E1). In particular, any illness that requires -
abdominal pressure reduces blood flow to inter- a patient to undergo large volume intravenous ated with poor perfusion states and hypoten-
nal organs, which can lead to multiple system fluid resuscitation can be associated with ACS; sion such as skin mottling, cool extremities,
failure and death if not promptly recognized the third-spacing of fluid can lead to increased and obtundation. Patients will often have
and treated. intraabdominal pressures secondary to tissue abdominal tenderness, signs of volume over-
edema. Due to large volume fluid resuscitation, load such as edema and elevated jugular
ICD-10CM CODE ACS is commonly seen in severe burns, trauma, venous pressures, and may present with
M79.A3 Nontraumatic compartment post-surgical patients, and sepsis. Other condi- acute respiratory decompensation.
syndrome of abdomen tions associated with ACS include intraabdomi-
nal and retroperitoneal pathologies such as sig- ETIOLOGY
EPIDEMIOLOGY & nificant bowel distention, liver transplantation, ACS can affect nearly every organ system.
DEMOGRAPHICS massive ascites, ruptured abdominal aortic High intraabdominal pressures are associated
INCIDENCE: Very few studies have examined aneurysm with resulting hemoperitoneum, pan- with increased intracranial pressures, which
the incidence of ACS outside of trauma patients, creatitis, and abdominal surgery (Table E2). can precipitate cerebral ischemia. Elevated
abdominal pressures can cause cardiac com-
pression by decreasing ventricular compliance
TABLE E1 Causes of Intraabdominal Hypertension and Abdominal and contractility as well as impairing inferior
Compartment Syndrome vena cava venous return, leading to increased
central venous and pulmonary pressures. Due
Increased Abdominal Contents Decreased Abdominal Volume to elevation of the diaphragm, patients will
often have reduced tidal volumes and lower
Ascites Reduction of large long-standing hernia chest wall compliance, which can lead to
Hemoperitoneum Direct closure of large, long-standing abdominal atelectasis, pneumonia, hypoxemia, and hyper-
wall defect carbia. Mechanically ventilated patients will also
Abdominal packs require increased airway pressures that can
lead to barotrauma. In addition, renal vein com-
Peritonitis
pression and renal artery vasoconstriction lead
Retroperitoneal edema (pancreatitis) Retroperitoneal edema (pancreatitis) to decreased urine output. Reduced mesenteric
Large pelvic, retroperitoneal hematoma Large pelvic, retroperitoneal hematoma blood flow can lead to intestinal ischemia and
Intestinal obstruction lactic acidosis.
Ileus
Gastric distention (esophageal ventilation) DIAGNOSIS
Abdominal aortic aneurysm
Severe constipation DIFFERENTIAL DIAGNOSIS
Large abdominal tumor (chronic)
Morbid obesity (chronic)
Pregnancy (chronic)
From Vincent JL et al: Textbook of critical care, ed 6, Philadelphia, 2011, Saunders.
WORKUP
Measurement of intraabdominal pressure is
TABLE E2 Independent Predictors of Postinjury Primary and Secondary required to make a definitive diagnosis. Bladder
Abdominal Compartment Syndrome pressure is the most common surrogate used
to estimate intraabdominal pressures and is
ED Model ICU Model measured using a bladder catheter. The most
accurate measurements can be obtained with
Independent Predictors Independent Predictors the patient in supine position at end expira-
tion in the absence of abdominal contractions.
Primary ACS To OR <75 min Temp ≤34° C The threshold abdominal pressure often set for
Crystalloids ≥3 L GAPco2 ≥16 research purposes to define ACS is >20 mm
Hb ≤8/dl Hg, but patients may have ACS with pressures
BD ≥12 mEq/L of >10 mm Hg and above. Oliguria tends to
Secondary ACS Crystalloids ≥3 L GAPco2 ≥16 develop at a pressure of 15 mm Hg, and anuria
occurs around 30 mm Hg. Intraabdominal pres-
No urgent surgery Crystalloids ≥7.5 L sures can also be estimated using intragastric,
PRBC ≥3 units UO ≤150 ml intracolonic, and inferior vena cava approaches
(Table E3).
ACS, Abdominal compartment syndrome; BD, arterial base deficit; CI, confidence interval; ED, emergency department; GAPco2,
carbon dioxide gap; Hb, hemoglobin concentration; ICU, intensive care unit; OR, operating room; PRBC, packed red blood cells;
Temp, temperature; UO, urine output.
From Vincent JL et al: Textbook of critical care, ed 6, Philadelphia, 2011, Saunders.
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
Abdominal Compartment Syndrome 6.e3
TABLE E3 Classification of
Abdominal Compartment
Syndrome
Basis of
Classification Subcategories
Time frame Acute
Chronic
Relation to peritoneal Primary
cavity Secondary
Etiology Trauma
Burn
Postoperative
Pancreatitis
Bowel obstruction FIG. E1 Open abdomen management of abdominal compartment syndrome. The sterile saline bag
was sewn to the skin edges. Closed suction drains were placed to limit fluid accumulation, and occlusive
Ileus dressing was applied to cover the abdominal wall. (Courtesy Brian J. Kimbrell, MD, In Vincent JL et al: Textbook
Abdominal aortic of critical care, ed 7, Philadelphia, 2017, Elsevier.)
aneurysm
Oncologic
Gynecologic
From Vincent JL et al: Textbook of critical care, ed 6, Philadel-
phia, 2011, Saunders.
LABORATORY TESTS
Laboratory testing is generally not helpful for
the diagnosis of ACS. The presence of lactic aci-
dosis suggests bowel ischemia, which portends
a poorer prognosis.
IMAGING STUDIES
Imaging alone has no diagnostic value in ACS,
but chest imaging can be helpful to evalu-
ate for diaphragmatic elevation and evidence
of pulmonary complications (atelectasis, vol-
ume overload, pneumonia, etc.). Abdominal FIG. E2 Open abdomen management of abdominal compartment syndrome using a vacuum-
computed tomography imaging will sometimes assisted closure (VAC) system. The bowel is covered with omentum if possible. Nonadherent dressing is
show renal displacement, inferior vena cava layered under a VAC sponge, or a smaller pore sponge is used against the viscera. Negative pressure is applied
compression, abdominal wall thickening, or to the wound closure to drain fluid, facilitate closure, and prevent evisceration. (Courtesy Brian J. Kimbrell, MD,
bowel injury related to ischemia but should not In Vincent JL et al: Textbook of critical care, ed 7, Philadelphia, 2017, Elsevier.)
be relied on to make the diagnosis of ACS.
-
TREATMENT decrease intraabdominal pressures, and sion for ACS has yet to be established; how-
some patients may require ventilatory sup- ever, data suggest that early decompression
Supportive care and, when appropriate, surgical port and chemical paralysis to maximize prior to the development of ACS may lead to
abdominal decompression are the mainstays of abdominal wall relaxation. better outcomes. If appropriate, consensus
ACS treatment. dictates that surgical decompression should
the high pressures that need to be generated to be performed on all patients with intraabdomi-
NONPHARMACOLOGIC THERAPY overcome the increased intraabdominal pres- nal pressure >25 mm Hg; however, some sur-
sures. Often a combination of low tidal volumes, geons are more aggressive and will consider
and ventilatory support, as well as techniques permissive hypercapnia, chemical paralysis, decompression with pressures of 15 to 25 mm
to improve abdominal wall compliance, are and high positive end-expiratory pressure are Hg in the right clinical setting. Surgical decom-
the foundations of ACS management. required to ensure adequate ventilatory support. pression (Fig. E1, Fig. E2) by incising vertically
through the linea alba can be performed at
will require surgical escharotomy to improve the administration of colloid may be superior the bedside in emergent situations and most
abdominal wall compliance. to crystalloid if the patient requires further surgeons will then keep the abdomen open
volume resuscitation. The administration of through the use of a temporary abdominal
will require large volume paracentesis to intravenous fluids will transiently increase closure device that retains heat/fluid and pre-
decrease intraabdominal pressures. renal blood flow, leading to increased urine vents evisceration until the time is appropriate
- output and improved organ perfusion and to attempt to close the abdomen again.
ble as any elevation of the head will increase cardiac output. Pressors may also have a
abdominal pressures. role to maintain perfusion pressures, but all ACUTE GENERAL Rx
of these measures are temporizing and sup- There are no direct pharmacologic agents
required if ACS is due to massive bowel portive until definitive action through surgical that treat ACS other than pressors, sedatives,
distention. decompression is performed. pain medications, and paralytics required for
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
Abdominal Compartment Syndrome 6.e4
supportive care as described above. Despite is most frequently estimated using bladder
underlying volume overload, diuretics have no PEARLS & pressure as a surrogate.
role in therapy. Definitive management is surgi- CONSIDERATIONS -
cal decompression. port with colloids, pressors, and ventilatory
COMMENTS support, is often required, but surgical decom-
DISPOSITION pression is the only definitive treatment.
-
Close inpatient monitoring, preferably in an cal patients, and its diagnosis requires both
intensive care setting, is indicated as mortality the presence of intraabdominal hypertension intraabdominal pressures >25 mm Hg; how-
can be extremely high (>40%) with ACS. and end organ dysfunction. ever, precise thresholds have not been estab-
lished, and earlier decompression may lead
REFERRAL to better outcomes.
to multisystem organ failure and is therefore
Patients with ACS often require admission to an associated with a high mortality. AUTHOR: Jason D. Ferreira, MD
intensive care setting with surgical consultation -
in case decompression is required. surement of intraabdominal pressure, which
SUGGESTED READINGS
Maluso P et al: Abdominal compartment hypertension and abdominal compartment
syndrome, Crit Care Clin 32:213-222, 2016.
Roberts DJ et al: Increased pressure within the abdominal compartment: intra-
abdominal hypertension and the abdominal compartment syndrome, Curr Opin
Crit Care 22:174-185, 2016.
Rogers WK et al: Intraabdominal hypertension, abdominal compartment syndrome
and the open abdomen, Chest 153(1):238-259, 2018.
Van Damme L et al: Effect of decompressive laparotomy on organ function in
patient with abdominal compartment syndrome: a systematic review and
meta-analysis, Crit Care 22(1):179, 2018.
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
ALG Abnormal Uterine Bleeding 7
and Disorders
Diseases
released a classification system intended to may suggest fibroids, or a polyp may be seen DIAGNOSIS
simplify these definitions. It is known by the acro- on the cervix during a speculum examination.
nym PALM-COEIN, described later. Today, AUB is DIFFERENTIAL DIAGNOSIS
described according to these criteria. Although many patients complain of the
A normal menstrual cycle is typically abnormality of their cycles, some will present
with symptoms of anemia, with AUB being 1. Polyps (AUB-P)
described as lasting 21 to 35 days with 5 days
of bleeding per cycle. Total blood loss for normal
menses is thought to be less than 80 ml.
elicited only with a careful history. Patients
may note recent weight gain or on examina-
2.
3.
Adenomyosis (AUB-A)
Leiomyoma (AUB-L) I
tion, may have other findings (as noted later) 4. Malignancy/hyperplasia (AUB-M)
SYNONYMS suggestive of the etiology for their bleeding. 5. Coagulopathy (AUB-C; most commonly
von Willebrand disease)
Abnormal uterine bleeding (AUB)
exclude the other causes of abnormal bleeding: 6. Ovulatory dysfunction (AUB-O; most com-
Dysfunctional uterine bleeding
1. Includes thyroid, breast, liver (e.g., pres- monly polycystic ovarian syndrome)
ICD-10CM CODES 7. Endometrial (AUB-E)
ence or absence of ecchymotic lesions)
N92.5 Other specified irregular menstruation 8. Iatrogenic (AUB-I; e.g., anticoagulants,
2. Patient habitus: Obese and hirsute (poly-
N92.0 Excessive and frequent menstruation hormonal contraception, and some herbal
cystic ovarian disease) or thin (think eat-
with regular cycle remedies)
ing disorders or excessive exercise)
N91.5 Oligomenorrhea, unspecified 9. Not yet classified (AUB-N)
3. Presence or absence of vulvar, vaginal,
N92.1 Excessive and frequent menstruation
or cervical lesions, uterine (fibroid) or
with irregular cycle 1. Cervical neoplasia, cervicitis
ovarian tumors, urethral caruncles or
N94.6 Dysmenorrhea, unspecified 2. Vaginal neoplasia, adhesions, trauma,
diverticula, hemorrhoids, anal fissures,
colorectal lesions foreign body, atrophic vaginitis, infec-
tions, condyloma
3. Vulvar trauma, infections, neoplasia, con-
TABLE 1 Definitions of Abnormal Uterine Bleeding
dyloma, dystrophy, varices
Term Description 4. Urinary tract: Urethral caruncle, diverticu-
lum, hematuria
Oligomenorrhea Bleeding at intervals greater than 35 days 5. Gastrointestinal tract: Hemorrhoids, anal
Polymenorrhea Bleeding at intervals less than 21 days fissure, colorectal lesions
Hypermenorrhea (menorrhagia) Excessive flow or bleeding with normal intervals
Metrorrhagia Bleeding between menses 1. Exogenous hormone intake: Hormone
Menometrorrhagia Excessive flow or duration with periods and between periods replacement therapy
Withdrawal bleeding Bleeding after the withdrawal of hormones
TABLE 3 Causes of Abnormal
Crum CP et al: Diagnostic gynecologic and obstetric pathology, ed 3, Philadelphia, 2018, Elsevier. Uterine Bleeding in the Fourth and
Fifth Decades
TABLE 2 Causes of Abnormal Uterine Bleeding Cause Differential Diagnosis
Age (Years) Causes (In Order of Decreasing Frequency) Anovulation
Prepubertal Precocious puberty (hypothalamic, pituitary, ovarian)
Endometrial
Adolescence polyp
leiomyoma
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
8 Abnormal Uterine Bleeding ALG
These proofs may contain color figures. Those figures may print black and white in the final printed book if a color print product has not been planned. The color figures will appear in color
in all electronic versions of this book.
Other documents randomly have
different content
détestait les Grignan, et les Grignan ne l'aimaient pas; de sorte que,
hormis ce qui avait trait à madame de Sévigné et à sa fille, il ne
désirait rien savoir de ce qui se passait autour d'elles. Voilà sans
doute le motif qui fit que Bussy interrompit pendant plus d'un an sa
correspondance avec sa cousine [696]. Mais si pourtant il négligea de
correspondre avec elle pendant le cours d'une année (depuis juillet
1672 jusqu'en juillet 1673), jamais il n'écrivit et ne reçut d'autres
personnes un plus grand nombre de lettres; jamais, quoique ayant
cinquante-cinq ans, il ne montra un plus grand désir de braver les
fatigues et les périls de la guerre, et de faire oublier son âge par ses
succès en amour. Ces passions surannées l'avaient lié avec un jeune
homme, l'abbé de Choisy, qui n'est plus connu heureusement
aujourd'hui que par de nombreux écrits non dépourvus d'agréments
et d'instruction et irréprochables sous le rapport de la religion et des
mœurs. L'abbé de Choisy avait quitté le nom de comtesse de Saincy
ou des Barres; il ne portait plus d'habits de femme, et, après un
voyage fait en Italie, il avait obtenu en 1663, par le crédit de sa
mère, l'abbaye de Saint-Seine en Bourgogne [697], ce qui le forçait à
résider souvent dans ce pays. Il avait à peine trente ans. Le temps
de ses métamorphoses en jeune et jolie fille était passé, mais non
pas les penchants qui y avaient donné lieu: seulement ils s'étaient
affaiblis. Il aimait toujours le jeu et les femmes. Lorsque le sort lui
avait été contraire, et qu'il était las de ses maîtresses, il quittait
Paris, et allait en Bourgogne se renfermer dans son abbaye avec la
résolution d'y résider pour faire des économies, et payer ses dettes.
L'ennui le prenait, et il allait continuellement à Paris et à Dijon [698].
Ses traits étaient restés délicats et mignards; mais l'âge et le soleil
d'Italie avaient donné à son charmant visage une apparence plus
mâle [699]. Il obtint sans artifice, sans aucun perfide déguisement de
nombreux succès auprès des femmes livrées à la galanterie [700]. A
Dijon, il en rencontra une à laquelle il rendit des soins, et il s'en fit
aimer; conquête plus facile à faire qu'à conserver: jeune, jolie,
spirituelle, elle avait en outre la réputation d'écrire très-bien des
lettres. Ce mérite était alors prisé dans la société et dans le monde
comme aujourd'hui celui de la musique: l'abbé de Choisy le
possédait, mais Bussy plus que personne.
La nouvelle maîtresse de l'abbé de Choisy était madame
Bossuet [701], femme de Bossuet, trésorier général des états de
Bourgogne, frère aîné de Jacques-Bénigne Bossuet. Elle était la fille
de Nicolas Dumont, gentilhomme de Bourgogne, et d'Anne-Catherine
de Hautoy, d'une maison distinguée de Lorraine. Nicolas Dumont
s'était attaché avec trois de ses frères à la fortune de Condé; il avait
suivi ce prince dans l'exil, et ce fut Condé qui, après sa rentrée en
France, maria la jeune et belle fille de Dumont, et procura à son
mari la place de trésorier général des états de Bourgogne. Ce
mariage eut lieu le 26 avril 1662; et, lors de la mort du père des
Bossuet, en 1667, madame Bossuet avait déjà deux fils. A l'époque
de son mariage, son mari était le personnage le plus notable de la
famille des Bossuet; il fut depuis intendant de Soissons et maître des
requêtes; mais, lors de sa liaison avec l'abbé de Choisy, le beau-frère
de madame Bossuet était l'évêque de Condom, le précepteur du
Dauphin, le grand Bossuet, alors à l'apogée de sa gloire et de sa
fortune [702].
Madame Bossuet désira entrer en correspondance avec Bussy, et
faire connaissance avec ce personnage célèbre dans toute la
Bourgogne. Elle manifesta ce désir à l'abbé de Choisy, qui mit
d'autant plus d'empressement [703] à la satisfaire que nulle pensée
jalouse ne le tourmentait à l'égard d'un rival dont l'âge était si fort
disproportionné avec le sien. Il écrivit à ce sujet à Bussy, qui,
toujours avide des louanges qu'on donnait à son esprit, ne manqua
pas, dans un voyage qu'il fit à Dijon pour ses affaires, de rendre
visite à madame Bossuet. Au moment de son départ ne l'ayant pas
trouvée chez elle, il lui fit ses adieux par une lettre où il lui
demandait son amitié [704]. Craignant sans doute le ridicule de se
commettre avec une si jeune et si belle femme, il mit peu
d'empressement à lui écrire; mais elle lui envoya la tragédie de
Bérénice de Racine, qui venait de paraître; et, à propos et sur le
sujet de cette pièce [705], il engagea avec elle une correspondance
suivie; de telle sorte que, peu à peu séduit par les louanges qu'elle
lui donnait, il finit par lui parler le langage de la galanterie et de
l'amour. C'est où elle avait voulu l'amener. L'abbé de Choisy était
retourné à Paris, et c'est à elle qu'il adressait les lettres qu'il écrivait
à Bussy, et qui de Dijon étaient transmises à ce dernier dans le lieu
de la Bourgogne où il se trouvait. De même Bussy faisait passer à
madame Bossuet les lettres qu'il écrivait à l'abbé de Choisy [706],
principalement pour qu'elle se procurât le plaisir d'en prendre
lecture, et qu'elles lui valussent de nouveaux éloges [707].
Comme madame Bossuet ne faisait aucun mystère des lettres que lui
écrivait Bussy, qu'elle en tirait même vanité, on sut dans toute la
Bourgogne, et même à Paris [708], que le comte de Bussy-Rabutin
entretenait une correspondance avec elle; et l'historien des Amours
des Gaules fut mis au nombre des amants de cette belle-sœur de
l'évêque de Condom. Madame de Montmorency, madame la
comtesse de la Roche et mademoiselle de Scudéry, qui recevait chez
elle l'abbé de Choisy, apprirent à Bussy que cela se disait à Paris [709].
Le 17 février 1673, madame de Scudéry écrivait [710]: «On dit que
madame Bossuet est cachée à Paris, et qu'on la fait chercher pour
l'enfermer dans un couvent. M. de Condom, son beau-frère, me loua
l'autre jour sa beauté et son esprit; mais je vois bien qu'il n'est pas
content de sa conduite. Est-il vrai, ne vous déplaise, que c'est vous
qui l'avez amenée à trois ou quatre lieues de Paris? Notre ami l'abbé
de Choisy a, dit-on, de grands soins d'elle. Il y a trois mois que je ne
l'ai vu: l'amour démonte extrêmement la cervelle.»
On pourrait croire que la beauté de madame Bossuet était connue
du roi, car madame de Scudéry termine sa lettre ainsi: «Vous me
deviez bien venir voir quand vous amenâtes madame Bossuet à
Paris. Je ne prétends pas que vous me veniez visiter malgré les
défenses du roi. Il ne pardonnerait pas un voyage qu'on ne ferait
que par amitié; mais je crois qu'il vous pardonnerait celui que vous
avez fait pour madame Bossuet, s'il le savait; car le tyran qui vous a
fait marcher est de sa connaissance [711].»
Mais en examinant cette correspondance avec attention, on
s'aperçoit qu'un certain marquis, amoureux de madame Bossuet,
s'était offert à elle pour servir d'intermédiaire entre elle et le roi, ce
qu'elle refusa, craignant des indiscrétions [712]. Bussy, qui n'était point
allé à Paris, répondit à mademoiselle Scudéry: «M. de Condom a
raison de vous louer la beauté et l'esprit de madame Bossuet, mais
surtout son esprit: personne ne l'a plus agréable qu'elle. Pour sa
conduite, ce n'est pas la même chose: elle ne plaît à personne, pas
même à ses amants en faveur, à qui elle est si mauvaise; et ce n'est
pas seulement comme beau-frère ou comme évêque que M. de
Condom y trouve à redire. Il a eu d'autres raisons; je ne sais si elles
durent encore.»
Cette perfide insinuation caractérise bien l'envie et la méchanceté de
Bussy. Il détestait Bossuet, non-seulement alors une des gloires de
la France, mais aussi une puissance en Bourgogne, par l'amitié
intime qui le liait au grand Condé, gouverneur de cette province et
ennemi déclaré de Bussy. L'amitié qui unissait Condé et Bossuet était
ancienne, et datait de la jeunesse de tous les deux. Lorsqu'âgé de
vingt et un ans Bossuet soutint sa thèse de bachelier, Condé, qui
n'en avait que vingt-six et qu'illustraient déjà les victoires de
Fribourg, de Nordlingue et de Dunkerque, avait assisté, avec tout
son état-major et les seigneurs de sa suite, au triomphe du jeune
théologien. Depuis lors il était resté son ami et son admirateur, et il
fut en toute occasion le protecteur de sa famille. Bussy avait des
moyens de donner de la consistance à ses calomnies sur l'évêque de
Condom. Il avait vu Bossuet très-jeune, avant qu'il fût entré dans les
ordres, présenté chez Fouquet par madame Duplessis-Guénégaud,
qui fut une de ses premières protectrices. Madame de Sévigné, dès
le commencement de son mariage, avait fait connaissance avec
Bossuet à l'hôtel de Rambouillet; et, depuis, elle eut des occasions
plus fréquentes encore de se lier plus familièrement avec lui, lorsqu'il
était un habitué de l'hôtel de Nevers [713]. L'historien du prélat est
obligé d'avouer qu'à cette époque le jeune Bossuet n'avait pas cette
sévérité de mœurs, cette répulsion pour les amusements mondains
qu'il manifesta depuis; qu'il fréquentait les spectacles et aimait la
comédie, bien qu'il la proscrivit depuis dans un de ses meilleurs
écrits. De dix enfants qu'avait eus le père Bossuet, Bénigne était le
septième; par conséquent son frère aîné était beaucoup plus âgé
que lui. Bénigne Bossuet était fort bel homme, et n'avait que trente-
quatre ans lors du mariage de sa belle-sœur. Mais, nonobstant ces
faits, les perfides insinuations de Bussy ne nuisaient alors qu'à lui-
même quand elles s'attaquaient à Bossuet [714]. La calomnie respecta
ce grand homme tant qu'il vécut, et elle n'osa essayer de noircir sa
vie que quand il fut descendu dans la tombe. Bussy, continuant sa
lettre, dit: «Où avez-vous appris cette belle nouvelle, que j'ai mené
madame Bossuet à Paris? Je vous assure qu'il n'y a rien de si faux.
«La vérité est que je ne l'ai pas vue depuis l'année passée, au mois
d'août, que je l'ai quittée à Dijon; et quoiqu'elle fût assez de mes
amies, je n'ai appris de ses nouvelles que par le bruit public. Elle a
été à Paris et puis en Lorraine, et puis est retournée à Paris, où elle
est (dites-vous) cachée, et l'abbé de Choisy avec elle [716].»
Dans une de ses lettres, Bussy dépeint ainsi madame Bossuet:
«C'est une des plus jolies femmes que j'aie jamais vues, de quelque
côté qu'on la regarde.» Il en parle aussi comme aimant à exciter la
passion sans la partager: ce qui était vrai pour lui, mais non pour
l'abbé de Choisy [717].
Les flatteries que Bussy adressait à madame Bossuet dans les lettres
qu'il lui écrivait prouvent qu'il n'eût pas demandé mieux que d'être
son amant: s'il en fut autrement, c'est que madame Bossuet,
entourée de plus jeunes galants, ne voulait pas pousser sa
correspondance romanesque avec Bussy jusqu'au dénoûment [718].
Cette correspondance était pour elle un exercice d'esprit et un
agréable entretien de confiance amicale; mais Bussy avait voulu
donner à ses flatteries et à ses lettres un sens plus prononcé, qui
tendit plus directement au but qu'il désirait atteindre; et il lui écrivit:
«On ne peut longtemps avoir de l'amitié pour vous sans trouver que
Patry avait raison de dire
Qu'il est malaisé
Que l'ami d'une jeune dame
Ne soit un amant déguisé [719].»
Elle répondit:
«Si Patry avait fait pour moi les vers que vous m'avez adressés, je lui
aurais répondu:
ÉCLAIRCISSEMENTS.
NOTES
ET
ÉCLAIRCISSEMENTS.
CHAPITRE PREMIER.
ebookmasss.com